Katharina F Bullok

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, represent the basic principle of multiple myeloma treatment. However, the development of resistance is a limiting factor. Over the last years, the efficient application of cytokine-induced killer (CIK) cells has been reported as an alternative strategy to treat hematological(More)
  • 1